Subtype
Malignant Reproductive System Neoplasm
CI-CAN-00001172Explore in graph →
2,804 active trials38 approved drugs186 evidence items
- NCIt
- C36076
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001172Explore in graph →
Clinical trials
12,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,473)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07331246 | TENS for Pain Relief During Fusion-Guided Prostate Biopsy | completed | N/A | 84 | Medical University of GdanskOTHER | 1 | Jan 9, 2026 | clinicaltrials |
| NCT03996005 | MRI- Guided Transurethral Ultrasound Ablation of Localized Prostate Cancer(MRI-TULSAP) | completed | N/A | 25 | University Hospital, Strasbourg, FranceOTHER | 1 | Jan 8, 2026 | clinicaltrials |
| NCT02189486 | Prostate Cancer Upgrading Reference Set | completed | — | 382 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jan 7, 2026 | clinicaltrials |
| NCT06173037 | RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer | completed | Phase 2 | 43 | RemeGen Co., Ltd.INDUSTRY | 1 | Jan 7, 2026 | clinicaltrials |
| NCT07250178 | ONSD as an ICP Marker in vNOTES and TLH | completed | N/A | 66 | Saglik Bilimleri Universitesi Gazi Yasargil Training and Research HospitalOTHER | 1 | Jan 7, 2026 | clinicaltrials |
| NCT06429163 | Pre-incisional Wound INfiltration and Hypogastric PLEXus Block Using Ropivacaine in Laparoscopic Myomectomy(WINPLEX) | completed | N/A | 207 | Saint Petersburg State University, RussiaOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT06839378 | Flura-seq for Evaluating the Effects of Different Hyperthermic Intraperitoneal Chemotherapy Regimens on the Transcriptome of Pseudomyxoma Peritonei | completed | N/A | 36 | Beijing Tsinghua Chang Gung HospitalOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT06840535 | A Study to Evaluate the Safety and Dosimetry of 68Ga-OncoACP3 in Patients With Prostate Cancer(OncoACP-3) | completed | Phase 1 | 20 | Philogen S.p.A.INDUSTRY | 1 | Jan 6, 2026 | clinicaltrials |
| NCT03734757 | Interest of Trimodality PET-CT Choline MRI Before Radiotherapy in High Risk Prostate Cancer(DEMETER) | completed | N/A | 20 | Centre Henri BecquerelOTHER | 1 | Jan 2, 2026 | clinicaltrials |
| NCT06016725 | Online Dietary and Resistance Training to Improve Physical Function in Older Cancer Survivors, E-PROOF Trial(E-PROOF) | completed | N/A | 75 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jan 2, 2026 | clinicaltrials |
| NCT00980954 | Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy | completed | Phase 3 | 236 | Radiation Therapy Oncology GroupNETWORK | 4 | Dec 31, 2025 | clinicaltrials |
| NCT01809691 | S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer(S1216) | completed | Phase 3 | 1,313 | SWOG Cancer Research NetworkNETWORK | 1 | Dec 31, 2025 | clinicaltrials |
| NCT07312825 | Effectiveness of Combined Fascial Plane Blocks for Postoperative Pain in Gynecologic Oncology Surgery | completed | — | 94 | Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research HospitalOTHER | 1 | Dec 31, 2025 | clinicaltrials |
| NCT01823549 | Nutritional Supplements & Complementary/Alternative Medicine by Prostate & Breast Cancer Patients | completed | — | 109 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Dec 29, 2025 | clinicaltrials |
| NCT03869216 | Fostering Shared Decision-making About Prostate Cancer Screening Among Clinicians and African American Men | completed | N/A | 161 | Xavier University of Louisiana.OTHER | 1 | Dec 29, 2025 | clinicaltrials |
| NCT07306195 | Comparison Between High and Low Level Para-aortic Lymphadenectomy in High and Intermediate Risk Endometrial Carcinoma | completed | N/A | 150 | Ahmed AoufOTHER | 1 | Dec 29, 2025 | clinicaltrials |
| NCT02657863 | Cancer DNA Detection in Blood and Urine | completed | — | 61 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Dec 23, 2025 | clinicaltrials |
| NCT04081636 | Prostate Biopsy, Transrectal vs. Transperineal: Efficacy and Complications(ProBE-PC) | completed | N/A | 840 | Albany Medical CollegeOTHER | 1 | Dec 23, 2025 | clinicaltrials |
| NCT05483933 | Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers | completed | Phase 1 | 86 | Shattuck Labs, Inc.INDUSTRY | 4 | Dec 23, 2025 | clinicaltrials |
| NCT06783088 | Quantification With Lutetium-177 on Cadmium-Zinc-Telluride Camera 3D(QUADO) | completed | — | 20 | Central Hospital, Nancy, FranceOTHER | 1 | Dec 23, 2025 | clinicaltrials |
| NCT06846099 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Indications of RP903 | completed | Phase 1 | 69 | Risen (Suzhou) Pharma Tech Co., Ltd.INDUSTRY | 1 | Dec 23, 2025 | clinicaltrials |
| NCT02985957 | A Study of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650)(CheckMate 650) | completed | Phase 2 | 351 | Bristol-Myers SquibbINDUSTRY | 10 | Dec 22, 2025 | clinicaltrials |
| NCT03027479 | Skeletal Muscle Energy Metabolism in Women With Weight Loss and Ovarian and/or Endometrial Cancer With Weight Loss(METERMUS-IMC) | completed | N/A | 70 | University Hospital, ToursOTHER | 1 | Dec 22, 2025 | clinicaltrials |
| NCT06055946 | Symmcora® Long-term Bidirectional Barbed Suture for Anastomosis in Patients Undergoing Robot Assisted Radical Prostatectomy(BARVANA LONG) | completed | — | 70 | Aesculap AGINDUSTRY | 1 | Dec 22, 2025 | clinicaltrials |
| NCT02001272 | EWOC-1 Trial: Carboplatin +/- Paclitaxel in Vulnerable Elderly Patients With Stage III-IV Advanced Ovarian Cancer(EWOC-1) | completed | Phase 2 | 120 | Hospices Civils de LyonOTHER | 6 | Dec 19, 2025 | clinicaltrials |
| NCT02485379 | Assessment of Prostate MRI Before Prostate Biopsies(MRI-FIRST01) | completed | N/A | 275 | Hospices Civils de LyonOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT02618200 | Creation of an Image Database for the Development of a Computer Aided Diagnostic (CAD) System in Patients With Prostate Cancer(Echo-CAD) | completed | N/A | 2 | Hospices Civils de LyonOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT02651948 | Transperineal, MRI-guided, Prostate Biopsy | completed | Phase 4 | 90 | University Hospital, Strasbourg, FranceOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT03959761 | Tolerance of Intraperitoneal (IP) Nivolumab After Extensive Debulking Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Ovarian Carcinoma(ICONIC) | completed | Phase 1 / Phase 2 | 22 | Hospices Civils de LyonOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT04037358 | RAdium-223 and SABR Versus SABR for Oligometastatic Prostate Cancers(RAVENS) | completed | Phase 2 | 64 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT04817449 | Spectroscopy in Ovarian Cancer | completed | — | 160 | University of ExeterOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT00117286 | Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer | completed | Phase 2 / Phase 3 | 57 | Ferring PharmaceuticalsINDUSTRY | 2 | Dec 18, 2025 | clinicaltrials |
| NCT03009981 | A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer | completed | Phase 3 | 504 | Alliance Foundation Trials, LLC.OTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT03466788 | Impact of Adjuvant Chemotherapy on the Quality of Life of Patients Treated for Stage II / III Endometrial Cancer(EndoQOL) | completed | N/A | 51 | Centre Francois BaclesseOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT04458402 | Adjuvant Hypofractionated Whole Pelvis Radiation Therapy in Endometrial Cancer | completed | N/A | 8 | Teresa MeierOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT02600156 | Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors | completed | N/A | 7 | Mayo ClinicOTHER | 1 | Dec 17, 2025 | clinicaltrials |
| NCT04051502 | ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: A Feasibility Study | completed | Early Phase 1 | 48 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 17, 2025 | clinicaltrials |
| NCT04707937 | Evaluation of a Brachytherapy Discharge Education Program to Improve Patient Care(BrachDEP) | completed | N/A | 150 | University Health Network, TorontoOTHER | 1 | Dec 16, 2025 | clinicaltrials |
| NCT05001347 | A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors | completed | Phase 2 | 25 | I-Mab Biopharma US LimitedINDUSTRY | 1 | Dec 16, 2025 | clinicaltrials |
| NCT07046949 | Anterior Quadratus Lumborum Block as a Component of Multimodal Analgesia for Abdominal Hysterectomies | completed | N/A | 56 | Yuri Semenyuk Rivne Regional Clinical HospitalOTHER | 1 | Dec 16, 2025 | clinicaltrials |
| NCT04157985 | Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors | completed | Phase 3 | 161 | Dan ZandbergOTHER | 1 | Dec 11, 2025 | clinicaltrials |
| NCT04339140 | Zafirlukast in Treatment of Marker Relapsed Ovarian Cancer | completed | Phase 2 | 5 | Beth Israel Deaconess Medical CenterOTHER | 1 | Dec 11, 2025 | clinicaltrials |
| NCT06462014 | Description of Relugolix Use in Patients With Prostate Cancer Within the VHA | completed | — | 507 | PfizerINDUSTRY | 1 | Dec 11, 2025 | clinicaltrials |
| NCT05650021 | Rectal Spacer for Prostate Cancer Radiation Image Guidance | completed | N/A | 17 | Milton S. Hershey Medical CenterOTHER | 1 | Dec 9, 2025 | clinicaltrials |
| NCT06094322 | Evaluation of Rapid T2-weighted and DWI MR Sequences Reconstructed by Deep Learning for Prostate Imaging(DLRPRO) | completed | N/A | 34 | Centre Hospitalier Universitaire, AmiensOTHER | 1 | Dec 8, 2025 | clinicaltrials |
| NCT07086651 | A Study to Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensitive Prostate Cancer (mCSPC) | completed | — | 1,300 | PfizerINDUSTRY | 1 | Dec 8, 2025 | clinicaltrials |
| NCT04501913 | Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes | completed | — | 22 | City of Hope Medical CenterOTHER | 1 | Dec 5, 2025 | clinicaltrials |
| NCT06125145 | Geriatric Assessment and Promotores (GAP) Pilot Feasibility Study(GAP) | completed | N/A | 30 | University of California, DavisOTHER | 1 | Dec 5, 2025 | clinicaltrials |
| NCT01089387 | Intracavernous Bone Marrow Stem-cell Injection for Post Prostatectomy Erectile Dysfunction(INSTIN) | completed | Phase 1 / Phase 2 | 18 | Institut National de la Santé Et de la Recherche Médicale, FranceOTHER_GOV | 1 | Dec 4, 2025 | clinicaltrials |
| NCT03232411 | Biobank for African American Prostate Cancer Research in Florida | completed | — | 592 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 4, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Jan 9, 2026source: clinicaltrials